Back to School: How biopharma can reboot drug development. Access exclusive analysis here

The First Word

The First Word

We encountered our first health care reform bumper sticker on Friday. The message - SINGLE PAYER - was flanked by what appeared (from the next freeway lane) to be a facsimile of the Clinton health security card.

It was a propitious encounter, because it reminded us of the mighty agenda the biotechnology industry faces

Read the full 565 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers